19-Mar-2020 | Facts and Factors
Findings from Facts and Factors report “POC Diagnostics Market By Product (hsTnI, BNP and NT-ProBNP, HbA1c, PCT, TSH & FT4, HIV POC, and Influenza POC) and By End User (Hospital, Home & Healthcare Centers, ACAD, Others): Europe and MEA Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global POC diagnostics market in 2019 was approximately USD 740.0 Million. The market is expected to grow at a CAGR of 7% and is anticipated to reach around USD 1200.00 Million by 2026.
The POC is known as Point of care diagnostics and medical diagnostic testing. Point of care diagnostic devices concentrated as POCT. POC testing procedures are recycled to get diagnostic effects though with the patient. These are devices used commonly in doctor‘s offices, ambulance, hospitals, and patient‘s homes. The main benefit of using POC diagnostic devices remains that it provides fast feedback on many medical tests. After the previous period here is a sequential possible shift after medicine, to preemptive medicine, predictive, and personalized. It can rely continuously upon the growth of monitoring devices and portable diagnostic for point of care testing. Point of care tests is one type of medical test that can be executed at the bedside. Many times, the simplicity remained not attainable until technologically advanced not simply to type of test possible formerly its mask is complexity. Some example, several types of urine test strips must be available for periods, and then portable ultrasonography did not range the stage of being affordably advanced, and widespread.
Browse the full “POC Diagnostics Market By Product (hsTnI, BNP and NT-ProBNP, HbA1c, PCT, TSH & FT4, HIV POC, and Influenza POC) and By End User (Hospital, Home & Healthcare Centers, ACAD, Others): Europe and MEA Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/poc-diagnostics-market-by-product-hstni-bnp-and-840
Technological improvement is continuous to growth in the usage of POC in home situations, on the smartphones that can monitor certain factors, and main care settings. Fast technological development is the foremost contributor to the growth of the POC market in the forecast period.
By product, the payment HSMs market is segmented intohsTnI, BNP and NT-ProBNP, HbA1c, PCT, TSH & FT4, HIV POC, and Influenza POC. HIV (Human Immunodeficiency Virus)POC is a virus that objects and changes the safe system, growing the risk and effect of further diseases and infections. It disruptions certain lockups in the protected system which are answerable and turns as body's protection alongside diseases. HIV is spread while blood, semen, and vaginal fluids since it is an infected person who arrives another person's body, typically over the sexual contact, sharing needles once vaccinating drugs, or mother to baby through birth. HIV is the worm that reasons AIDS and inhibits the body's facility to fight infections. HIV POC tests are also called as rapid tests and used to shade for HIV antibodies in the blood.
By end-user the payment HSMs market is segmented into Hospital, Home & Healthcare Centers, ACAD, Others. Hospital, an institute that is made, equipped, and staffed for the analysis of disease, and treatment. The new hospital too regularly helps as a focus for investigation and training. The hospitals are of two types, public and private hospitals. By increasing, needs hospitals are established into specialty categories like pediatric hospitals, orthopedics, gynecology, and others. Hospital's division accounted for important revenue share, as furthermost of the processes remain completed in hospitals fixed by the increasing amount of patient appointments.
The global payment HSMs market report profiles some of the key players operating in the market. The key players in the market are F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, bioMérieux SA, Nova Biomedical, Becton Dickinson & Company, Siemens Healthcare GmbH, Trividia Health Inc., QIAGEN, Sekisui Diagnostics LLC, Quidel Corporation, and others.
This report segments the POC diagnostics market as follows:
Europe and MEAPOC Diagnostics Market: By Product Segmentation Analysis
- BNP and NT-ProBNP
- TSH & FT4
- HIV POC
- Influenza POC
Europe and MEAPOC Diagnostics Market: By End User Segmentation Analysis
- Home & Healthcare Centers
Europe and MEAPOC Diagnostics Market: Regional Segmentation Analysis
- The UK
- Rest of Europe
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Facts & Factors
Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450